Toggle menu

ENCEPH UK Study

Start date:
March 2015
End date:
December 2015 (Close to recruitment)
Co-ordinated by:
Brain Infections UK, University of Liverpool
Main trial site:
http://www.encephuk.org/studies

To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.

 

Aim

To produce a predictive tool for HSV encephalitis based on the early clinical features, by comparing the clinical features of those with and without HSV encephalitis.

Trial Design

A Prospective multi-centre cohort observational study.

Eligibility criteria (summary of )

Patients who present to the Emergency Department or Acute Medical Unit with suspected encephalitis

Chief Investigator

Professor Tom Solomon

Local PI

Dr Matt Reed

Research Team

EMERGE Research team in collaboration with the Acute Medical Unit (AMU), Critical Care and the Virology team at the RIE

Further information

For more information please refer to main trial website  

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Polly Black

Senior Research Nurse

Julia Grahamslaw

Lead Research Nurse

More EMERGE Trials

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA Study

Identification of Novel Psychoactive Substances (IONA)

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more

NOVEL Study

Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions

Evaluating the role of early CT Coronary Angiography on patients with suspected or confirmed Acute Coronary Syndrome.

Read more

RAPID-CTCA Trial

Evaluating the role of early CT Coronary Angiography